P R Ebeling

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint Bone turnover markers and bone density across the menopausal transition
    P R Ebeling
    Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    J Clin Endocrinol Metab 81:3366-71. 1996
  2. ncbi request reprint Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management
    P R Ebeling
    Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Victoria, Australia
    Drugs Aging 13:421-34. 1998
  3. ncbi request reprint A prospective study of bone loss in menopausal Australian-born women
    J R Guthrie
    Department of Psychiatry, Royal Melbourne Hospital, Victoria, Australia
    Osteoporos Int 8:282-90. 1998
  4. ncbi request reprint Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation
    A B D'Souza
    Department of Clinical Haematology and Medical Oncology, Clinical Haematology and Bone Marrow Transplant Service, Melbourne, Victoria, Australia
    Intern Med J 36:600-3. 2006
  5. doi request reprint A review of the clinical implications of bisphosphonates in dentistry
    G L Borromeo
    Melbourne Dental School, The University of Melbourne, Victoria, Australia
    Aust Dent J 56:2-9. 2011
  6. ncbi request reprint Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study
    K L Bennell
    School of Physiotherapy, University of Melbourne, Australia
    Bone 20:477-84. 1997
  7. ncbi request reprint Role of biochemical markers in the management of osteoporosis
    P R Ebeling
    Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia
    Best Pract Res Clin Rheumatol 15:385-400. 2001
  8. ncbi request reprint Pamidronate reduces bone loss after allogeneic stem cell transplantation
    A P Grigg
    Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia
    J Clin Endocrinol Metab 91:3835-43. 2006
  9. ncbi request reprint Teriparatide (rhPTH 1-34) for the treatment of osteoporosis
    P R Ebeling
    Department of Diabetes, The University of Melbourne, Royal Melbourne Hospital, Australia
    Int J Clin Pract 57:710-8. 2003
  10. doi request reprint Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab)
    C Gagnon
    Department of Medicine, University of Melbourne, Western Hospital, Melbourne, Australia
    Osteoporos Int 21:2067-74. 2010

Detail Information

Publications16

  1. ncbi request reprint Bone turnover markers and bone density across the menopausal transition
    P R Ebeling
    Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    J Clin Endocrinol Metab 81:3366-71. 1996
    ..In conclusion, the perimenopause is associated with elevated bone resorption rates and declining BMD, and factors in addition to estrogen deficiency may also contribute to the pathogenesis of postmenopausal osteoporosis...
  2. ncbi request reprint Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management
    P R Ebeling
    Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Victoria, Australia
    Drugs Aging 13:421-34. 1998
    ..Effective public health measures also need to be established and targeted to men at risk of developing the disease...
  3. ncbi request reprint A prospective study of bone loss in menopausal Australian-born women
    J R Guthrie
    Department of Psychiatry, Royal Melbourne Hospital, Victoria, Australia
    Osteoporos Int 8:282-90. 1998
    ..05), such that women with higher BMI had less bone loss. In conclusion, during the time of transition from peri- to post-menopause, women had accelerated BMD loss at both the hip and spine...
  4. ncbi request reprint Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation
    A B D'Souza
    Department of Clinical Haematology and Medical Oncology, Clinical Haematology and Bone Marrow Transplant Service, Melbourne, Victoria, Australia
    Intern Med J 36:600-3. 2006
    ..8% (range, -27.6 to +24.4%). Four patients continued to lose bone from the spine post-ZA. ZA reduces bone loss in most patients after alloHSCT. Our data require confirmation in a larger prospective, randomized study...
  5. doi request reprint A review of the clinical implications of bisphosphonates in dentistry
    G L Borromeo
    Melbourne Dental School, The University of Melbourne, Victoria, Australia
    Aust Dent J 56:2-9. 2011
    ..In the context of substantial uncertainty, the implications of bisphosphonate use in the dental clinical setting are still being determined...
  6. ncbi request reprint Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study
    K L Bennell
    School of Physiotherapy, University of Melbourne, Australia
    Bone 20:477-84. 1997
    ..Our results provide further support for the concept that bone response to mechanical loading depends upon the bone site and the mode of exercise...
  7. ncbi request reprint Role of biochemical markers in the management of osteoporosis
    P R Ebeling
    Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia
    Best Pract Res Clin Rheumatol 15:385-400. 2001
    ..Thus, the transition of biochemical bone markers into everyday clinical practice may be rapidly approaching...
  8. ncbi request reprint Pamidronate reduces bone loss after allogeneic stem cell transplantation
    A P Grigg
    Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia
    J Clin Endocrinol Metab 91:3835-43. 2006
    ..Rapid bone loss occurs from the proximal femur after allogeneic stem cell transplantation (alloSCT). Objective: The objective of the study was to evaluate effects of high-dose pamidronate therapy on bone loss (BMD) after alloSCT...
  9. ncbi request reprint Teriparatide (rhPTH 1-34) for the treatment of osteoporosis
    P R Ebeling
    Department of Diabetes, The University of Melbourne, Royal Melbourne Hospital, Australia
    Int J Clin Pract 57:710-8. 2003
    ..When given by once-daily injection, teriparatide increases bone mass by stimulating formation of new bone, resulting in the restoration of bone architecture...
  10. doi request reprint Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab)
    C Gagnon
    Department of Medicine, University of Melbourne, Western Hospital, Melbourne, Australia
    Osteoporos Int 21:2067-74. 2010
    ....
  11. ncbi request reprint Association between knee cartilage volume and bone mineral density in older adults without osteoarthritis
    F Cicuttini
    Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Prahran 3181, Victoria, Australia
    Rheumatology (Oxford) 43:765-9. 2004
    ..We conducted a cross-sectional study to determine the relationship between knee cartilage volume, a direct measure of joint cartilage, and bone mineral density (BMD) in an adult population...
  12. ncbi request reprint Vitamin D deficiency in general medical inpatients in summer and winter
    S M Chatfield
    Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Intern Med J 37:377-82. 2007
    ..These patients often have coexistent risk factors for its consequences. This study aims to document a point prevalence of vitamin D deficiency in this population...
  13. ncbi request reprint Vitamin D deficiency is common and unrecognized among recently arrived adult immigrants from The Horn of Africa
    S A Skull
    Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
    Intern Med J 33:47-51. 2003
    ..Routine assessment for vitamin D deficiency should be considered for male and female immigrants from East Africa...
  14. ncbi request reprint Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor
    S J King
    Nutrition Dept, Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
    Eur Respir J 25:54-61. 2005
    ..In conclusion, reduced bone mineral density in cystic fibrosis is associated with a number of factors, including DeltaF508 genotype, male sex, greater lung disease severity and malnutrition...
  15. ncbi request reprint Factors affecting knee cartilage volume in healthy men
    F M Cicuttini
    Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Prahran 3181, Australia
    Rheumatology (Oxford) 42:258-62. 2003
    ..To understand the factors that influence joint cartilage in health and disease as they are important for the prevention and management of osteoarthritis...
  16. ncbi request reprint Predictors of bone mineral density in aging healthy men varies by skeletal site
    B L Clarke
    Division of Endocrinology and Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Calcif Tissue Int 70:137-45. 2002
    ..We conclude that predictor variables of bone density vary by skeletal site in healthy men. Alterations in adrenal androgens, phosphate, and PTH may be important in the pathogenesis of bone loss with aging in men...